Bart Jessen

Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model

Shihao Chen, Li‐Fen Lee, Timothy S. Fisher et al. · Cancer Immunology Research · 2014 · 275 citations · Full text

Life Sciences, Immunology, Oncology +17

Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells

Yvonne Will, James A. Dykens, Sashi Nadanaciva et al. · Toxicological Sciences · 2008 · 215 citations

Life Sciences, Oncology, Pharmacology +17

A high content screening assay for identifying lysosomotropic compounds

Sashi Nadanaciva, Shuyan Lu, David F. Gebhard et al. · Toxicology in Vitro · 2010 · 205 citations

Life Sciences, Biochemistry, Molecular Biology +11

Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies

Wenyue Hu, Tae Sung, Bart Jessen et al. · Clinical Cancer Research · 2015 · 167 citations

Medicine, Oncology, Pharmacology +15

Lysosomal adaptation: How cells respond to lysosomotropic compounds

Shuyan Lu, Tae Sung, Nianwei Lin et al. · PLoS ONE · 2017 · 156 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17